Skip to main content
Premium Trial:

Request an Annual Quote

QIMR Installs Bruker Daltonics' maXis Mass Spectrometer

NEW YORK (GenomeWeb News) — The Queensland Institute of Medical Research has installed one of Bruker Daltonics’ mass spectrometers for use in its proteomics research, Bruker said today.
 
QIMR, located in Brisbane, Australia, will use the company’s maXis instruments in its Protein Discovery Center. The maXis system is used in quantitative proteomics, peptide and intact protein analysis, and small molecule identification.
 
Bruker said that this agreement marks the first installation of this high-resolution, time-of-flight model in the Australasia region.
 
Bruker Daltonics Executive VP Clive Seymour called the installation “a major opportunity for us to co-develop a wide range of applications undertaken” at the PDC.
 
“In particular, it will provide the PDC with the scope to collaborate more effectively with scientists from QIMR, Australia and internationally on projects aimed at combating infectious diseases and cancer,” explained PDC Director Jeff Gorman in a statement.
 
Financial terms of the agreement were not released.
 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.